Yunus Emre DÖNMEZ, Özlem ÖZEL ÖZCAN, Fatma KARTAL SARİOGLU, Sümeyra GÜNGÖREN

Management of obsessive compulsive disorder induced by the use of clozapine

The second generation antipsychotic of clozapine has superior efficacy compared to other antipsychotics especially for treatment-resistant schizophrenia. In up to 20% of patients receiving clozapine treatment, the side effect of obsessive compulsive symptoms or obsessive compulsive disorder occurs. These obsessive compulsive side effects sometimes cause cessation of the use of clozapine and sometimes causes difficulties in treating the psychotic symptoms due to dose reductions. This manuscript presents a case with resistant schizophrenia who developed obsessive compulsive disorder secondary to clozapine treatment and was successfully treated with clomipramine and aims to discuss the case accompanied by the literature.

PDF

___

Kane J, Singer MD, Meltzer MD. Clozapine for the treatment-resistant. Arch Gen Psychiatry. 1988;45:789-96.

Bleakley S, Brown D, Taylor D. Does clozapine cause or worsen obsessive compulsive symptoms? An analysis and literature review. Ther Adv Psychopharmacol. 2011;1:181-8.

Schirmbeck F, Zink M. Clozapine-induced obsessive-compulsive symptoms in schizophrenia: a critical review. Curr Neuropharmacol. 2012;10:88-95.

Fonseka TM, Richter MA, Müller DJ. Second generation antipsychoticinduced obsessive-compulsive symptoms in schizophrenia: a review of the experimental literature. Curr Psychiatry Rep. 2014;16:510.

Swets M, Dekker J, van Emmerik-van Oortmerssen K, et al. The obsessive compulsive spectrum in schizophrenia, a meta-analysis and meta-regression exploring prevalence rates. Schizophr Res. 2014;152:458-68.

Sterk B, Lankreijer K, Linszen DH, et al. Obsessive–compulsive symptoms in first episode psychosis and in subjects at ultra high risk for developing psychosis; onset and relationship to psychotic symptoms. Aust N Z J Psychiatry. 2011;45:400-6.

Lin SK, Su SF, Pan CH. Higher plasma drug concentration in clozapinetreated schizophrenic patients with side effects of obsessive/compulsive symptoms. Ther Drug Monit. 2006;28:303-7.

Ertugrul A, Yagcioglu AEA, Eni N, et al. Obsessive-compulsive symptoms in clozapine-treated schizophrenic patients. Psychiatry Clin Neurosci. 2005;59:219-22.

Milad MR, Rauch SL. Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways. Trends Cogn Sci. 2012;16:43-51.

Menzies L, Chamberlain SR, Laird AR, et al. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neurosci Biobehav Rev. 2008;32:525-49.

Cai J, Zhang W, Yi Z, et al. Influence of polymorphisms in genes SLC1A1, GRIN2B, and GRIK2 on clozapine induced obsessive compulsive symptoms. Psychopharmacology. 2013;230:49-55.

Zink M, Englisch S, Knopf U, Kuwilsky A, Dressing H. Augmentation of clozapine with valproic acid for clozapine-induced obsessive-compulsive symptoms. Pharmacopsychiatry. 2007;40:202–3.

Canan F, Aydinoglu U, Sinani G. Valproic acid augmentation in clozapineassociated hand-washing compulsion. Psychiatry Clin Neurosci. 2012;66:4634.

Biondi M, Fedele L, Arcangeli T, et al. Development of obsessive-compulsive symptoms during clozapine treatment in schizophrenia and its positive response to clomipramine. Psychother Psychosom. 1999;68:111-2.

Leung JG, Palmer BA. Psychosis or Obsessions? Clozapine Associated with Worsening Obsessive-Compulsive Symptoms. Case Rep Psychiatry. 2016.

Coskun M, Zoroglu S. Clozapine induced obsessions treated with sertraline in an adolescent with schizophrenia. Klinik Psikofarmakol Bulteni. 2009;19:155-8.